Patent US3922292A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3922292A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel haptene steroids

Assignee: Sanofi Aventis France
•
Filing: 1974-06-17
•
Granted: 1975-11-25
•
Expires: 1994-06-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel steroids of the formula WHEREIN X is selected from the group consisting of O and, Y is selected from the group consisting of hydrogen and -OH and when R1 is -(CH2)a-COOH in which a is equal to 2n + 3 and n is 0, 1 or 2, R2 is and when R1 is hydrogen, R2 is selected from the group consisting of AND N-Z-(CH2)c-COOH, b is a number from 3 to 18, c is a number from 1 to 8 and Z is selected from the group consisting of -Oand -NHCONH- which are haptenes or compounds capable of producing antibodies in vitro but are derived of antigenic properties and their preparation.

Inventors

  • 👤 Vesperto Torelli
  • 👤 Andre Pierdet

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 17:12
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/74; G01N33/743; A; A61; A61P; A61P37/00; A61P37/02; A61P37/04; C; C07; C07J; C07J1/00; C07J1/0051; C07J1/0059; C07J1/0066; C07J1/007; C07J41/00; C07J41/0005; C07J71/00; C07J71/0005; C07J71/001; Y; Y10; Y10S; Y10S436/00; Y10S436/823

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 5 words
A STEROID OF THE FORMULA
Claim 2
Dependent Claim 5 words
A STEROID OF THE FORMULA
Claim 3
Dependent Claim 22 words
A compound of claim 1 wherein R1 is -(CH2)a-COOH, a 2n + 3, n is 0, 1 or 2 and R2 is
Claim 4
Dependent Claim 24 words
A compound of claim 2 selected from the group consisting of Delta 1,3,5(10)-estratriene-3,17 Beta -diol-11 Beta -butyric acid and Delta 1,3,5(10)-estratriene-3-ol-17-one-11 Beta -butyric acid.
Claim 5
Dependent Claim 13 words
A compound of claim 1 in which R1 is hydrogen and R2 is
Claim 6
Dependent Claim 40 words
A compound of claim 4 selected from the group consisting of Delta 1,3,5(10)-estratriene-3,17 Beta -diol-7 Alpha -butyric acid, Delta 1,3,5(10)-estratriene-3-ol-17-one-7 Alpha -butyric acid, Delta 1,3,5(10)-estratriene-3,16 Alpha ,17 Beta -triol-7 Alpha -butyric acid and Delta 1,3,5(10)-estratriene-3,17 Beta -diol-7 Alpha -undecanoic acid.
Claim 7
Dependent Claim 13 words
A compound of claim 1 wherein R1 is hydrogen and R2 is NZ(CH2)c-COOH.
Claim 8
Dependent Claim 28 words
A compound of claim 6 which is selected from the group consisting of 7-carboxymethoxyimino- Delta 1,3,5(10)-estratriene-3,17 Beta -diol, 7-carboxymethoxyimino- Delta 1,3,5(10)-estratriene-3-ol-17-one and 4''-carboxymethyl-2''-semicarbazone of Delta 1,3,5(10)-estratriene-3,17 Beta -diol-7-one.
Claim 9
Dependent Claim 18 words
A process for the preparation of a compound of claim 2 comprising reacting a compound of the formula
Claim 10
Dependent Claim 18 words
A process for the preparation of a compound of claim 4 comprising reacting a steroid of the formula

References Cited (Backward Citations)

US3211756A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-11-24 1979-05-26 1979-11-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-11-24 1983-05-26 1983-11-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-11-24 1987-05-26 1987-11-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag